Since results for m/m trial are getting closer, wh
Post# of 148186
(Total Views: 553)
Posted On: 07/16/2020 7:54:51 AM
Since results for m/m trial are getting closer, why not do a little prediction contest: what will the parameters/results look like?
As a reminder, primary endpoint is
Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough) [ Time Frame: Day 14 ]
Note: The total score per patient ranges from 0 to 12 points. Each symptom is graded from 0 to 3. [0=none, 1=mild, 2=moderate, and 3=severe]. Higher scores mean a worse outcome.
Name Placebo (mean) leronlimab (mean)
Baseline Day 14 Baseline Day 14
lorbas 3.8 4.1 3.6 1.7
As a reminder, primary endpoint is
Clinical Improvement as assessed by change in total symptom score (for fever, myalgia, dyspnea and cough) [ Time Frame: Day 14 ]
Note: The total score per patient ranges from 0 to 12 points. Each symptom is graded from 0 to 3. [0=none, 1=mild, 2=moderate, and 3=severe]. Higher scores mean a worse outcome.
Name Placebo (mean) leronlimab (mean)
Baseline Day 14 Baseline Day 14
lorbas 3.8 4.1 3.6 1.7
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼